FBRX - CIK 0001419041
Forte Biosciences, Inc. has filed 595 documents with the SEC between 2007 and 2026. The most frequent type is insider trade (178 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Quarterly report | 10-Q | 2025-05-15 | 2025-03-31 |
| SCHEDULE 13G/A | - | 2025-05-14 | - |
| Annual report to shareholders | ARS | 2025-04-30 | 2024-12-31 |
| Proxy statement | DEF 14A | 2025-04-30 | 2025-05-29 |
| Major company event | 8-K | 2025-04-18 | 2025-04-18 |
| Major company event | 8-K | 2025-04-04 | 2025-03-31 |
| EFFECT | - | 2025-04-03 | - |
| Insider trade | 4 | 2025-04-02 | 2025-04-01 |
| Insider trade | 4 | 2025-04-02 | 2025-04-01 |
| Company correspondence | CORRESP | 2025-04-01 | - |
| SEC correspondence | UPLOAD | 2025-04-01 | - |
| Securities registration | S-3 | 2025-03-28 | - |
| Annual report | 10-K | 2025-03-28 | 2024-12-31 |
| Insider trade | 4 | 2025-03-21 | 2025-03-20 |
| Insider trade | 4 | 2025-03-21 | 2025-03-20 |
| Insider trade | 4 | 2025-03-21 | 2025-03-20 |
| Insider trade | 4 | 2025-03-21 | 2025-03-20 |
| Insider trade | 4 | 2025-03-21 | 2025-03-20 |
| Insider trade | 4 | 2025-03-21 | 2025-03-20 |
| Insider trade | 4 | 2025-03-21 | 2025-03-20 |
| Insider trade | 4 | 2025-03-21 | 2025-03-20 |
| Insider trade | 4 | 2025-03-21 | 2025-03-19 |
| SCHEDULE 13G | - | 2025-02-14 | - |
| SCHEDULE 13G/A | - | 2025-02-14 | - |
| SCHEDULE 13G/A | - | 2025-02-14 | - |
| SCHEDULE 13G | - | 2025-02-14 | - |
| SCHEDULE 13G | - | 2025-02-14 | - |
| SCHEDULE 13G/A | - | 2025-02-14 | - |
| SCHEDULE 13G/A | - | 2025-02-14 | - |
| SCHEDULE 13G | - | 2025-02-13 | - |
| SCHEDULE 13G/A | - | 2025-02-10 | - |
| Employee stock plan | S-8 | 2025-02-07 | - |
| Major company event | 8-K | 2025-01-24 | 2025-01-24 |
| SCHEDULE 13G | - | 2025-01-10 | - |
| Insider trade | 4 | 2025-01-02 | 2025-01-01 |
| Insider trade | 4 | 2025-01-02 | 2025-01-01 |
| Proxy statement | DEF 14A | 2024-12-31 | 2025-01-24 |
| EFFECT | - | 2024-12-20 | - |
| 424B3 | - | 2024-12-20 | - |
| Company correspondence | CORRESP | 2024-12-18 | - |
| SEC correspondence | UPLOAD | 2024-12-16 | - |
| Securities registration | S-3 | 2024-12-13 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-12-06 | - |
| Major company event | 8-K | 2024-12-03 | 2024-12-03 |
| Insider trade | 4 | 2024-11-22 | 2024-11-21 |
| Major company event | 8-K | 2024-11-20 | 2024-11-19 |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Major company event | 8-K | 2024-11-14 | 2024-11-14 |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Quarterly report | 10-Q | 2024-11-14 | 2024-09-30 |